VERITONE INC (VERI)

US92347M1009 - Common Stock

3.36  +0.08 (+2.6%)

After market: 3.39 +0.03 (+0.89%)

Fundamental Rating

1

Overall VERI gets a fundamental rating of 1 out of 10. We evaluated VERI against 277 industry peers in the Software industry. Both the profitability and financial health of VERI have multiple concerns. VERI is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year VERI has reported negative net income.
VERI had a negative operating cash flow in the past year.
In the past 5 years VERI always reported negative net income.
In multiple years VERI reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -15.60%, VERI is not doing good in the industry: 61.68% of the companies in the same industry are doing better.
With a Return On Equity value of -153.68%, VERI is not doing good in the industry: 78.10% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.6%
ROE -153.68%
ROIC N/A
ROA(3y)-11.37%
ROA(5y)-23.66%
ROE(3y)-86.84%
ROE(5y)-89.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VERI has a better Gross Margin (77.85%) than 76.28% of its industry peers.
In the last couple of years the Gross Margin of VERI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for VERI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y0.4%

0

2. Health

2.1 Basic Checks

VERI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VERI has been increased compared to 1 year ago.
The number of shares outstanding for VERI has been increased compared to 5 years ago.
Compared to 1 year ago, VERI has a worse debt to assets ratio.

2.2 Solvency

VERI has an Altman-Z score of -1.87. This is a bad value and indicates that VERI is not financially healthy and even has some risk of bankruptcy.
VERI's Altman-Z score of -1.87 is on the low side compared to the rest of the industry. VERI is outperformed by 78.47% of its industry peers.
VERI has a Debt/Equity ratio of 3.53. This is a high value indicating a heavy dependency on external financing.
VERI has a Debt to Equity ratio of 3.53. This is amonst the worse of the industry: VERI underperforms 84.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.53
Debt/FCF N/A
Altman-Z -1.87
ROIC/WACCN/A
WACC7.67%

2.3 Liquidity

VERI has a Current Ratio of 0.97. This is a bad value and indicates that VERI is not financially healthy enough and could expect problems in meeting its short term obligations.
VERI has a worse Current ratio (0.97) than 79.20% of its industry peers.
VERI has a Quick Ratio of 0.97. This is a bad value and indicates that VERI is not financially healthy enough and could expect problems in meeting its short term obligations.
VERI's Quick ratio of 0.97 is on the low side compared to the rest of the industry. VERI is outperformed by 78.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97

4

3. Growth

3.1 Past

The earnings per share for VERI have decreased strongly by -113.04% in the last year.
Looking at the last year, VERI shows a very negative growth in Revenue. The Revenue has decreased by -14.81% in the last year.
The Revenue has been growing by 36.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-113.04%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-420%
Revenue 1Y (TTM)-14.81%
Revenue growth 3Y30.27%
Revenue growth 5Y36.42%
Revenue growth Q2Q-22.08%

3.2 Future

Based on estimates for the next years, VERI will show a very strong growth in Earnings Per Share. The EPS will grow by 37.31% on average per year.
VERI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.58% yearly.
EPS Next Y63.05%
EPS Next 2Y37.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.79%
Revenue Next 2Y5.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VERI. In the last year negative earnings were reported.
Also next year VERI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

VERI's earnings are expected to grow with 37.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.31%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VERI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERITONE INC

NASDAQ:VERI (5/3/2024, 7:24:34 PM)

After market: 3.39 +0.03 (+0.89%)

3.36

+0.08 (+2.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap126.71M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.6%
ROE -153.68%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 77.85%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 3.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-113.04%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y63.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.81%
Revenue growth 3Y30.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y